The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Liquid Formulations Drug Delivery Market Research Report 2025
Synopsis
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
The global Liquid Formulations Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liquid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Formulations Drug Delivery.
Report Scope
The Liquid Formulations Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid Formulations Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Formulations Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
Segment by Type
Suspensions
Solutions
Segment by Application
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Formulations Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Suspensions are defined as finely divided undissolved drugs dispersed in liquid vehicles. They can be a ready-to-use liquid suspension or a dry powder reconstitutable suspension, which is dispersed in water by the patient, a caregiver or a pharmacist. Solutions are defined as liquid preparations in which the drug and the various excipients are dissolved in the suitable solvent or aqueous system.
The global Liquid Formulations Drug Delivery market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Liquid Formulations Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liquid Formulations Drug Delivery.
Report Scope
The Liquid Formulations Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liquid Formulations Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Liquid Formulations Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
3M
Merck & Co
Crescita Therpeautics
Novartis International
Boehringer Ingelheim
Pfizer
Teva Pharmaceuticals
Bristol Myers Squibb
Lead Chemical
Purdue Pharma
Glenmark Pharmaceuticals
Galderma
Johnson & Johnson Private
GlaxoSmithKline
Bausch Health Companies
Hisamitsu Pharmaceuticals
Cipla
Bayer
Viatris
Segment by Type
Suspensions
Solutions
Segment by Application
Home Care Settings
Hospitals & Clinics
Burn Centers
Other Facilities
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liquid Formulations Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liquid Formulations Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Suspensions
1.2.3 Solutions
1.3 Market by Application
1.3.1 Global Liquid Formulations Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Home Care Settings
1.3.3 Hospitals & Clinics
1.3.4 Burn Centers
1.3.5 Other Facilities
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liquid Formulations Drug Delivery Market Perspective (2019-2030)
2.2 Liquid Formulations Drug Delivery Growth Trends by Region
2.2.1 Global Liquid Formulations Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liquid Formulations Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Liquid Formulations Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Liquid Formulations Drug Delivery Market Dynamics
2.3.1 Liquid Formulations Drug Delivery Industry Trends
2.3.2 Liquid Formulations Drug Delivery Market Drivers
2.3.3 Liquid Formulations Drug Delivery Market Challenges
2.3.4 Liquid Formulations Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liquid Formulations Drug Delivery Players by Revenue
3.1.1 Global Top Liquid Formulations Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Liquid Formulations Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Liquid Formulations Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liquid Formulations Drug Delivery Revenue
3.4 Global Liquid Formulations Drug Delivery Market Concentration Ratio
3.4.1 Global Liquid Formulations Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liquid Formulations Drug Delivery Revenue in 2023
3.5 Liquid Formulations Drug Delivery Key Players Head office and Area Served
3.6 Key Players Liquid Formulations Drug Delivery Product Solution and Service
3.7 Date of Enter into Liquid Formulations Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liquid Formulations Drug Delivery Breakdown Data by Type
4.1 Global Liquid Formulations Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Liquid Formulations Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Liquid Formulations Drug Delivery Breakdown Data by Application
5.1 Global Liquid Formulations Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Liquid Formulations Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liquid Formulations Drug Delivery Market Size (2019-2030)
6.2 North America Liquid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liquid Formulations Drug Delivery Market Size by Country (2019-2024)
6.4 North America Liquid Formulations Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liquid Formulations Drug Delivery Market Size (2019-2030)
7.2 Europe Liquid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liquid Formulations Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Liquid Formulations Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liquid Formulations Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Liquid Formulations Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liquid Formulations Drug Delivery Market Size (2019-2030)
9.2 Latin America Liquid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liquid Formulations Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Liquid Formulations Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liquid Formulations Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Liquid Formulations Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 3M
11.1.1 3M Company Detail
11.1.2 3M Business Overview
11.1.3 3M Liquid Formulations Drug Delivery Introduction
11.1.4 3M Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.1.5 3M Recent Development
11.2 Merck & Co
11.2.1 Merck & Co Company Detail
11.2.2 Merck & Co Business Overview
11.2.3 Merck & Co Liquid Formulations Drug Delivery Introduction
11.2.4 Merck & Co Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.2.5 Merck & Co Recent Development
11.3 Crescita Therpeautics
11.3.1 Crescita Therpeautics Company Detail
11.3.2 Crescita Therpeautics Business Overview
11.3.3 Crescita Therpeautics Liquid Formulations Drug Delivery Introduction
11.3.4 Crescita Therpeautics Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.3.5 Crescita Therpeautics Recent Development
11.4 Novartis International
11.4.1 Novartis International Company Detail
11.4.2 Novartis International Business Overview
11.4.3 Novartis International Liquid Formulations Drug Delivery Introduction
11.4.4 Novartis International Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.4.5 Novartis International Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Detail
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Liquid Formulations Drug Delivery Introduction
11.5.4 Boehringer Ingelheim Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Liquid Formulations Drug Delivery Introduction
11.6.4 Pfizer Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Teva Pharmaceuticals
11.7.1 Teva Pharmaceuticals Company Detail
11.7.2 Teva Pharmaceuticals Business Overview
11.7.3 Teva Pharmaceuticals Liquid Formulations Drug Delivery Introduction
11.7.4 Teva Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.7.5 Teva Pharmaceuticals Recent Development
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Detail
11.8.2 Bristol Myers Squibb Business Overview
11.8.3 Bristol Myers Squibb Liquid Formulations Drug Delivery Introduction
11.8.4 Bristol Myers Squibb Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.8.5 Bristol Myers Squibb Recent Development
11.9 Lead Chemical
11.9.1 Lead Chemical Company Detail
11.9.2 Lead Chemical Business Overview
11.9.3 Lead Chemical Liquid Formulations Drug Delivery Introduction
11.9.4 Lead Chemical Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.9.5 Lead Chemical Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Detail
11.10.2 Purdue Pharma Business Overview
11.10.3 Purdue Pharma Liquid Formulations Drug Delivery Introduction
11.10.4 Purdue Pharma Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.10.5 Purdue Pharma Recent Development
11.11 Glenmark Pharmaceuticals
11.11.1 Glenmark Pharmaceuticals Company Detail
11.11.2 Glenmark Pharmaceuticals Business Overview
11.11.3 Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Introduction
11.11.4 Glenmark Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.11.5 Glenmark Pharmaceuticals Recent Development
11.12 Galderma
11.12.1 Galderma Company Detail
11.12.2 Galderma Business Overview
11.12.3 Galderma Liquid Formulations Drug Delivery Introduction
11.12.4 Galderma Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.12.5 Galderma Recent Development
11.13 Johnson & Johnson Private
11.13.1 Johnson & Johnson Private Company Detail
11.13.2 Johnson & Johnson Private Business Overview
11.13.3 Johnson & Johnson Private Liquid Formulations Drug Delivery Introduction
11.13.4 Johnson & Johnson Private Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.13.5 Johnson & Johnson Private Recent Development
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Detail
11.14.2 GlaxoSmithKline Business Overview
11.14.3 GlaxoSmithKline Liquid Formulations Drug Delivery Introduction
11.14.4 GlaxoSmithKline Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.14.5 GlaxoSmithKline Recent Development
11.15 Bausch Health Companies
11.15.1 Bausch Health Companies Company Detail
11.15.2 Bausch Health Companies Business Overview
11.15.3 Bausch Health Companies Liquid Formulations Drug Delivery Introduction
11.15.4 Bausch Health Companies Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.15.5 Bausch Health Companies Recent Development
11.16 Hisamitsu Pharmaceuticals
11.16.1 Hisamitsu Pharmaceuticals Company Detail
11.16.2 Hisamitsu Pharmaceuticals Business Overview
11.16.3 Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Introduction
11.16.4 Hisamitsu Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.16.5 Hisamitsu Pharmaceuticals Recent Development
11.17 Cipla
11.17.1 Cipla Company Detail
11.17.2 Cipla Business Overview
11.17.3 Cipla Liquid Formulations Drug Delivery Introduction
11.17.4 Cipla Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.17.5 Cipla Recent Development
11.18 Bayer
11.18.1 Bayer Company Detail
11.18.2 Bayer Business Overview
11.18.3 Bayer Liquid Formulations Drug Delivery Introduction
11.18.4 Bayer Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.18.5 Bayer Recent Development
11.19 Viatris
11.19.1 Viatris Company Detail
11.19.2 Viatris Business Overview
11.19.3 Viatris Liquid Formulations Drug Delivery Introduction
11.19.4 Viatris Revenue in Liquid Formulations Drug Delivery Business (2019-2024)
11.19.5 Viatris Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Liquid Formulations Drug Delivery Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Suspensions
Table 3. Key Players of Solutions
Table 4. Global Liquid Formulations Drug Delivery Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Liquid Formulations Drug Delivery Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Liquid Formulations Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Liquid Formulations Drug Delivery Market Share by Region (2019-2024)
Table 8. Global Liquid Formulations Drug Delivery Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Liquid Formulations Drug Delivery Market Share by Region (2025-2030)
Table 10. Liquid Formulations Drug Delivery Market Trends
Table 11. Liquid Formulations Drug Delivery Market Drivers
Table 12. Liquid Formulations Drug Delivery Market Challenges
Table 13. Liquid Formulations Drug Delivery Market Restraints
Table 14. Global Liquid Formulations Drug Delivery Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Liquid Formulations Drug Delivery Market Share by Players (2019-2024)
Table 16. Global Top Liquid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Formulations Drug Delivery as of 2023)
Table 17. Ranking of Global Top Liquid Formulations Drug Delivery Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Liquid Formulations Drug Delivery Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Liquid Formulations Drug Delivery Product Solution and Service
Table 21. Date of Enter into Liquid Formulations Drug Delivery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Liquid Formulations Drug Delivery Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Liquid Formulations Drug Delivery Revenue Market Share by Type (2019-2024)
Table 25. Global Liquid Formulations Drug Delivery Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Liquid Formulations Drug Delivery Revenue Market Share by Type (2025-2030)
Table 27. Global Liquid Formulations Drug Delivery Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Liquid Formulations Drug Delivery Revenue Market Share by Application (2019-2024)
Table 29. Global Liquid Formulations Drug Delivery Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Liquid Formulations Drug Delivery Revenue Market Share by Application (2025-2030)
Table 31. North America Liquid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Liquid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Liquid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Liquid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Liquid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Liquid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Liquid Formulations Drug Delivery Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Liquid Formulations Drug Delivery Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Liquid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Liquid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Liquid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Liquid Formulations Drug Delivery Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Liquid Formulations Drug Delivery Market Size by Country (2025-2030) & (US$ Million)
Table 46. 3M Company Detail
Table 47. 3M Business Overview
Table 48. 3M Liquid Formulations Drug Delivery Product
Table 49. 3M Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 50. 3M Recent Development
Table 51. Merck & Co Company Detail
Table 52. Merck & Co Business Overview
Table 53. Merck & Co Liquid Formulations Drug Delivery Product
Table 54. Merck & Co Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 55. Merck & Co Recent Development
Table 56. Crescita Therpeautics Company Detail
Table 57. Crescita Therpeautics Business Overview
Table 58. Crescita Therpeautics Liquid Formulations Drug Delivery Product
Table 59. Crescita Therpeautics Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 60. Crescita Therpeautics Recent Development
Table 61. Novartis International Company Detail
Table 62. Novartis International Business Overview
Table 63. Novartis International Liquid Formulations Drug Delivery Product
Table 64. Novartis International Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 65. Novartis International Recent Development
Table 66. Boehringer Ingelheim Company Detail
Table 67. Boehringer Ingelheim Business Overview
Table 68. Boehringer Ingelheim Liquid Formulations Drug Delivery Product
Table 69. Boehringer Ingelheim Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 70. Boehringer Ingelheim Recent Development
Table 71. Pfizer Company Detail
Table 72. Pfizer Business Overview
Table 73. Pfizer Liquid Formulations Drug Delivery Product
Table 74. Pfizer Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. Teva Pharmaceuticals Company Detail
Table 77. Teva Pharmaceuticals Business Overview
Table 78. Teva Pharmaceuticals Liquid Formulations Drug Delivery Product
Table 79. Teva Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 80. Teva Pharmaceuticals Recent Development
Table 81. Bristol Myers Squibb Company Detail
Table 82. Bristol Myers Squibb Business Overview
Table 83. Bristol Myers Squibb Liquid Formulations Drug Delivery Product
Table 84. Bristol Myers Squibb Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 85. Bristol Myers Squibb Recent Development
Table 86. Lead Chemical Company Detail
Table 87. Lead Chemical Business Overview
Table 88. Lead Chemical Liquid Formulations Drug Delivery Product
Table 89. Lead Chemical Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 90. Lead Chemical Recent Development
Table 91. Purdue Pharma Company Detail
Table 92. Purdue Pharma Business Overview
Table 93. Purdue Pharma Liquid Formulations Drug Delivery Product
Table 94. Purdue Pharma Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 95. Purdue Pharma Recent Development
Table 96. Glenmark Pharmaceuticals Company Detail
Table 97. Glenmark Pharmaceuticals Business Overview
Table 98. Glenmark Pharmaceuticals Liquid Formulations Drug Delivery Product
Table 99. Glenmark Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 100. Glenmark Pharmaceuticals Recent Development
Table 101. Galderma Company Detail
Table 102. Galderma Business Overview
Table 103. Galderma Liquid Formulations Drug Delivery Product
Table 104. Galderma Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 105. Galderma Recent Development
Table 106. Johnson & Johnson Private Company Detail
Table 107. Johnson & Johnson Private Business Overview
Table 108. Johnson & Johnson Private Liquid Formulations Drug Delivery Product
Table 109. Johnson & Johnson Private Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 110. Johnson & Johnson Private Recent Development
Table 111. GlaxoSmithKline Company Detail
Table 112. GlaxoSmithKline Business Overview
Table 113. GlaxoSmithKline Liquid Formulations Drug Delivery Product
Table 114. GlaxoSmithKline Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 115. GlaxoSmithKline Recent Development
Table 116. Bausch Health Companies Company Detail
Table 117. Bausch Health Companies Business Overview
Table 118. Bausch Health Companies Liquid Formulations Drug Delivery Product
Table 119. Bausch Health Companies Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 120. Bausch Health Companies Recent Development
Table 121. Hisamitsu Pharmaceuticals Company Detail
Table 122. Hisamitsu Pharmaceuticals Business Overview
Table 123. Hisamitsu Pharmaceuticals Liquid Formulations Drug Delivery Product
Table 124. Hisamitsu Pharmaceuticals Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 125. Hisamitsu Pharmaceuticals Recent Development
Table 126. Cipla Company Detail
Table 127. Cipla Business Overview
Table 128. Cipla Liquid Formulations Drug Delivery Product
Table 129. Cipla Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 130. Cipla Recent Development
Table 131. Bayer Company Detail
Table 132. Bayer Business Overview
Table 133. Bayer Liquid Formulations Drug Delivery Product
Table 134. Bayer Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 135. Bayer Recent Development
Table 136. Viatris Company Detail
Table 137. Viatris Business Overview
Table 138. Viatris Liquid Formulations Drug Delivery Product
Table 139. Viatris Revenue in Liquid Formulations Drug Delivery Business (2019-2024) & (US$ Million)
Table 140. Viatris Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liquid Formulations Drug Delivery Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Liquid Formulations Drug Delivery Market Share by Type: 2023 VS 2030
Figure 3. Suspensions Features
Figure 4. Solutions Features
Figure 5. Global Liquid Formulations Drug Delivery Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Liquid Formulations Drug Delivery Market Share by Application: 2023 VS 2030
Figure 7. Home Care Settings Case Studies
Figure 8. Hospitals & Clinics Case Studies
Figure 9. Burn Centers Case Studies
Figure 10. Other Facilities Case Studies
Figure 11. Liquid Formulations Drug Delivery Report Years Considered
Figure 12. Global Liquid Formulations Drug Delivery Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Liquid Formulations Drug Delivery Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Liquid Formulations Drug Delivery Market Share by Region: 2023 VS 2030
Figure 15. Global Liquid Formulations Drug Delivery Market Share by Players in 2023
Figure 16. Global Top Liquid Formulations Drug Delivery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liquid Formulations Drug Delivery as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Liquid Formulations Drug Delivery Revenue in 2023
Figure 18. North America Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Liquid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 20. United States Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Liquid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 24. Germany Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Liquid Formulations Drug Delivery Market Share by Region (2019-2030)
Figure 32. China Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Liquid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 40. Mexico Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Liquid Formulations Drug Delivery Market Share by Country (2019-2030)
Figure 44. Turkey Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Liquid Formulations Drug Delivery Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. 3M Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 47. Merck & Co Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 48. Crescita Therpeautics Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 49. Novartis International Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 50. Boehringer Ingelheim Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 51. Pfizer Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 52. Teva Pharmaceuticals Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 53. Bristol Myers Squibb Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 54. Lead Chemical Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 55. Purdue Pharma Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 56. Glenmark Pharmaceuticals Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 57. Galderma Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 58. Johnson & Johnson Private Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 60. Bausch Health Companies Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 61. Hisamitsu Pharmaceuticals Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 62. Cipla Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 63. Bayer Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 64. Viatris Revenue Growth Rate in Liquid Formulations Drug Delivery Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
